Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis
- 1 December 2006
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 70 (12), 2109-2115
- https://doi.org/10.1038/sj.ki.5001983
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Effect of antihypertensive treatment with candesartan or amlodipine on glutathione and its redox status, homocysteine and vitamin concentrations in patients with essential hypertensionJournal Of Hypertension, 2005
- Role of Asymmetrical Dimethylarginine in Renal Microvascular Endothelial Dysfunction in Chronic Renal Failure with HypertensionHypertension Research, 2005
- Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney diseaseKidney International, 2004
- Effect of Shear Stress on Asymmetric Dimethylarginine Release From Vascular Endothelial CellsHypertension, 2003
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002
- Plasma F2-isoprostane levels are elevated in chronic hemodialysis patientsClinical Nephrology, 2002
- State of the ArgCell, 2001
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000
- Higher levels of antioxidant defenses in enalapril-treated versus non–enalapril-treated hemodialysis patientsAmerican Journal of Kidney Diseases, 1999
- Membrane Antioxidant Effects of the Charged Dihydropyridine Calcium Antagonist AmlodipineJournal of Molecular and Cellular Cardiology, 1999